POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization
Pomdoctor Limited announced progress in its AI-enabled chronic disease management ecosystem, including system optimization, expanded real-world data (RWD) applications, and integrated in-hospital and out-of-hospital management pilots. The company states its AI system leverages multidimensional healthcare data to refine models and support personalized strategies for continuous, data-driven chronic disease management.
Pomdoctor's update details its AI chronic disease management system, which has undergone multiple optimization rounds. This system integrates real-world healthcare data, including medication, diagnosis, patient behavior, monitoring, and payment information. The intent is to use this data to refine AI models, supporting physicians in evaluating health trends and developing personalized management strategies, thereby transitioning towards a more continuous and predictive approach to chronic care.
The company is also progressing with the commercial application of its RWD capabilities. This involves pharmaceutical real-world studies, evidence-based research collaborations, B2B healthcare data services, and partnerships with third-party healthcare institutions. The RWD ecosystem, which includes physiological, medication, behavioral, remote patient monitoring, and insurance-related data, is positioned as a multidimensional foundation for healthcare research and patient management, identified as a core value driver within Pomdoctor's revenue structure.
Additionally, Pomdoctor is advancing integrated in-hospital and out-of-hospital chronic disease management pilots. These pilots, facilitated by its physician service network and digital healthcare infrastructure, aim to extend chronic disease management beyond isolated clinical encounters. The model is designed for ongoing monitoring, physician follow-up, medication management, and personalized intervention, connecting technology capabilities with practical execution in healthcare scenarios.
Share this article
Related reading
6 stories
Superhuman pushes its Go assistant everywhere

After Jensen Huang’s exit, Nvidia speeds up pay reviews. Will it help retain staff?
Stuck in the Pile: Why India's answer sheets need an AI rescue

Anthropic's historic debut to put AI's promise and peril on Wall St trial

The US-China AI Race Is Real But Trump's Recent Moves On 'Super Intelligence' Are Unlikely To Give America Any Advantage #US-China #Race #Real #Trump's #Recent #Moves #'Super #Intelligence' #Unlikely #Give #America #Advantage #USA #Russia #Biden #Ukraine #War #Palestine #Gaza #Israel #

